Healthcare Supply Chain Compliance: Vendor Management, Contract Negotiation, Tariff Impact, and Other Challenges
A live 90-minute CLE video webinar with interactive Q&A
This CLE webinar will guide healthcare counsel in examining the legal risks that often exist in supply chains. The panel will discuss how careful due diligence, thoughtful contract negotiation, and effective policies and procedures can mitigate risk. The panel will also offer insights into how the new administration's proposed or imposed tariffs may impact the supply chain and contractual negotiations.
Outline
- Introduction
- Supply chain risks and healthcare companies
- Mitigating supply chain risks
- Policies and procedures to have in place
- Vetting and selection of vendors
- Identifying vendors as business associates
- Negotiating, drafting, and managing supply chain contracts
- Insights into new and/or proposed tariffs and the potential impact on supply chains and contractual terms
- Strategies for ensuring regulatory compliance
Benefits
The panel will review these and other key issues:
- What are the key supply chain risks facing healthcare companies and providers?
- What questions should healthcare companies and providers ask during the supplier vetting process to minimize the likelihood of selecting a risky supplier?
- What key terms should be negotiated in the supplier contract to help mitigate supply chain risks? How may these be impacted by the new administration's tariff policy?
Faculty
Monica R. Chmielewski
Partner, Vice Chair Health Care Practice Group
Foley & Lardner
Ms. Chmielewski’s practice is solely focused on the representation of healthcare providers, pharmaceutical and... | Read More
Ms. Chmielewski’s practice is solely focused on the representation of healthcare providers, pharmaceutical and medical device companies, and pharmacies in healthcare, healthcare transactions, clinical research, supply chain, and food and drug law. She provides daily counsel to numerous health systems, hospitals, academic medical centers, pharmacies, and biotech, pharmaceutical and medical device companies. Ms. Chmielewski regularly assists clients with the following issues: regulatory compliance governing all aspects of clinical research, investigations of research misconduct, Institutional Review Board issues, the conduct of U.S. and international clinical trials, research grants and funding, government investigations and audits, pharmaceutical product promotion (including counsel on off-label promotion), 510K applications, the regulation of software as a medical device, preparation of research contracts, among other matters.
CloseEarly Discount (through 07/11/25)